新冠疫情影响坦桑尼亚男性单剂HPV疫苗接种信任与接种的定性研究
本研究基于Add-Vacc整群随机试验,于2023年5月至2024年5月在坦桑尼亚西北部采用谣言追踪工具、关键知情人访谈、深度访谈、焦点小组讨论和快速民族志等方法,探讨疫苗与新冠谣言对14-18岁男性单剂HPV疫苗接种接受度的影响。结果显示,2020至2022年坦桑尼亚新冠政策变化引发不信任,出现试验疫苗为隐藏新冠疫苗、用于减少人口或影响生育力/男性性征等谣言;快速评估谣言并持续开展社区沟通有助于提升接种接受度。
要点
- 新冠政策频繁变化削弱了社区对疫苗项目的信任。
- 关于试验疫苗的谣言涉及隐藏新冠疫苗、减少人口及影响生育力。
- 早期监测谣言并持续社区沟通可支持接种接受度。
核心结论
- 新冠疫情期间政策变化影响了Add-Vacc试验中男性HPV疫苗的信任与接受度。
- 早期记录和监测社区关切可为动态社区沟通提供依据,促进利益相关方与实施团队间的对话和信任。
研究设计与样本
- 定性研究,嵌套于Add-Vacc整群随机试验。
- 2023年5月至2024年5月,在坦桑尼亚西北部收集谣言数据,方法包括电子谣言追踪工具、关键知情人访谈、深度访谈、焦点小组讨论和快速民族志。
- 研究对象包括青少年、家长、教师、卫生工作者和社区领袖等利益相关者。
主要发现
- 社区成员(包括青年)认为2020至2022年坦桑尼亚新冠政策变化引发了对试验疫苗的不信任和担忧。
- 记录的担忧包括对国家领导和疫苗接种计划动机的质疑。
- 谣言称试验提供的疫苗是隐藏的新冠疫苗、用于减少人口或导致生育力和/或男性性征改变。
- 快速评估试验相关谣言并开展有针对性的持续社区沟通活动,支持了提升疫苗接种接受度的努力。
临床怎么用
- 在向新人群提供疫苗的项目早期,应记录和监测社区关切。
- 基于谣言监测开展持续、动态的社区沟通,以促进对话和建立信任。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic impacted public health services and vaccination uptake globally. Trust in health services and vaccination programmes is critical for vaccine acceptance. Between 2020 and 2022, Tanzania shifted its acknowledgement of COVID-19 and its prevention strategies. National COVID-19 vaccination coverage reached 51% by April 2023. The Add-Vacc cluster-randomised trial (CRT) provided single-dose, human papillomavirus (HPV) vaccination to 14-18-year-old males in 2023-2024, the first time HPV vaccination was offered to young men in Tanzania. The Tanzania national vaccination programme promotes HPV vaccination for girls as the vaccine to prevent cervical cancer. OBJECTIVE: This qualitative study investigated the influence of vaccine and COVID-19 rumours on uptake of male HPV vaccination offered through the trial. METHODS: Between May 2023 to May 2024, field teams collected rumours data using an electronic-rumours tracking tool, key informant interviews, in-depth interviews, focus group discussions and rapid ethnography with stakeholders including adolescents, parents, teachers, health workers and community leaders. RESULTS: Data from community members, including youth, indicated that changes in Tanzania's COVID-19 policies between 2020 and 2022 prompted mistrust and concerns about the trial vaccine. Documented concerns included questions regarding the motives of national leadership and vaccination programmes, rumours that the vaccine offered through the trial was a concealed COVID-19 vaccine or was for- depopulation or led to changes in fertility and/or male virility. Rapid assessment of trial-related rumours and responsive, ongoing community engagement activities to address rumours supported efforts to enhance vaccination uptake and acceptance. CONCLUSION: Shifting COVID-19 policies during the height of the SARS-CoV-2 pandemic subsequently influenced trust and HPV vaccine acceptance during the vaccination phase of the Add-Vacc CRT. Documenting and monitoring community concerns early in a project delivering a vaccine to a new population group can inform ongoing, dynamic community engagement aimed towards promoting dialogue and building trust across stakeholder groups and implementation teams.
引用
- Malibwa D, Lees S, Ewing V, et al. Influence of COVID-19 and COVID-19 rumours on trust and uptake of single-dose male HPV vaccination in the Add-Vacc cluster-randomised trial, northwest Tanzania. Vaccine. 2026. PMID: 42854550. doi:10.1016/j.vaccine.2026.129231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。